Literature for peptide Pep2-8 (S08.039 inhibitor)

(Topics flags: S Structure, I Inhibitor. To select only the references relevant to a single topic, click the link above. See explanation.)

2020
1. Shingai,Y., Kimura,N., Doijiri,R., Takahashi,K., Yokosawa,M., Kanoke,A., Kikuchi,T., Sugawara,T. and Tominaga,T.
   Effect of preoperative administration of proprotein convertase subtilisin/kexin type 9 inhibitor on carotid artery stenting
   World Neurosurg135, e36-e36. PubMed  Europe PubMed DOI  I
2019
2. Lammi,C., Sgrignani,J., Arnoldi,A. and Grazioso,G.
   Biological characterization of computationally designed analogs of peptide TVFTSWEEYLDWV (Pep2-8) with increased PCSK9 antagonistic activity
   Sci Rep9, 2343-2343. PubMed  Europe PubMed DOI  I
3. Palee,S., McSweeney,C.M., Maneechote,C., Moisescu,D.M., Jaiwongkam,T., Kerdphoo,S., Chattipakorn,S.C. and Chattipakorn,N.
   PCSK9 inhibitor improves cardiac function and reduces infarct size in rats with ischaemia/reperfusion injury: benefits beyond lipid-lowering effects
   J Cell Mol Med23, 7310-7319. PubMed  Europe PubMed DOI  I
2017
4. Zhang,Y., Ultsch,M., Skelton,N.J., Burdick,D.J., Beresini,M.H., Li,W., Kong-Beltran,M., Peterson,A., Quinn,J., Chiu,C., Wu,Y., Shia,S., Moran,P., Di Lello,P., Eigenbrot,C. and Kirchhofer,D.
   Discovery of a cryptic peptide-binding site on PCSK9 and design of antagonists
   Nat Struct Mol Biol24, 848-856. PubMed  Europe PubMed DOI  I
2014
5. Zhang,Y., Eigenbrot,C., Zhou,L., Shia,S., Li,W., Quan,C., Tom,J., Moran,P., Di Lello,P., Skelton,N.J., Kong-Beltran,M., Peterson,A. and Kirchhofer,D.
   Identification of a small peptide that inhibits PCSK9 protein binding to the low density lipoprotein receptor
   J Biol Chem289, 942-955. PubMed  Europe PubMed DOI  S  I